130 related articles for article (PubMed ID: 1722105)
1. The DNA-dependent and RNA-dependent DNA polymerase activities of the reverse transcriptases of human immunodeficiency viruses types 1 and 2.
Shaharabany M; Hizi A
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):883-8. PubMed ID: 1722105
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the DNA polymerase and ribonuclease H activities of human immunodeficiency virus type 2 reverse transcriptase expressed in Escherichia coli.
Hizi A; Tal R; Hughes SH
Virology; 1991 Jan; 180(1):339-46. PubMed ID: 1701948
[TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Hizi A; Tal R; Shaharabany M; Loya S
J Biol Chem; 1991 Apr; 266(10):6230-9. PubMed ID: 1706712
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.
Hizi A; Hughes SH; Shaharabany M
Virology; 1990 Apr; 175(2):575-80. PubMed ID: 1691564
[TBL] [Abstract][Full Text] [Related]
5. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.
Sevilya Z; Loya S; Hughes SH; Hizi A
J Mol Biol; 2001 Aug; 311(5):957-71. PubMed ID: 11531332
[TBL] [Abstract][Full Text] [Related]
6. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Shaharabany M; Hizi A
J Biol Chem; 1992 Feb; 267(6):3674-8. PubMed ID: 1371274
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
[TBL] [Abstract][Full Text] [Related]
8. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
Hizi A; Shaharabany M; Tal R; Hughes SH
J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
[TBL] [Abstract][Full Text] [Related]
9. 3,5,8-Trihydroxy-4-quinolone, a novel natural inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Loya S; Rudi A; Tal R; Kashman Y; Loya Y; Hizi A
Arch Biochem Biophys; 1994 Mar; 309(2):315-22. PubMed ID: 7510944
[TBL] [Abstract][Full Text] [Related]
10. Expression and mutational analysis of the reverse transcriptase of the lentivirus equine infectious anemia virus.
Shaharabany M; Rice NR; Hizi A
Biochem Biophys Res Commun; 1993 Oct; 196(2):914-20. PubMed ID: 7694581
[TBL] [Abstract][Full Text] [Related]
11. The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is modulated by residue 294 of the small subunit.
Sevilya Z; Loya S; Adir N; Hizi A
Nucleic Acids Res; 2003 Mar; 31(5):1481-7. PubMed ID: 12595556
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of novel selective mutants of the reverse transcriptase of human immunodeficiency virus type 1.
Hizi A; Shaharabany M
J Biol Chem; 1992 Sep; 267(26):18255-8. PubMed ID: 1382052
[TBL] [Abstract][Full Text] [Related]
13. Cross-clade inhibition of recombinant human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus SIVcpz reverse transcriptases by RNA pseudoknot aptamers.
Held DM; Kissel JD; Thacker SJ; Michalowski D; Saran D; Ji J; Hardy RW; Rossi JJ; Burke DH
J Virol; 2007 May; 81(10):5375-84. PubMed ID: 17329328
[TBL] [Abstract][Full Text] [Related]
14. The effects of cysteine mutations on the catalytic activities of the reverse transcriptase of human immunodeficiency virus type-1.
Loya S; Tal R; Hughes SH; Hizi A
J Biol Chem; 1992 Jul; 267(20):13879-83. PubMed ID: 1378433
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the fingers and palm subdomains of human immunodeficiency virus type-1 (HIV-1) reverse transcriptase.
Boyer PL; Ferris AL; Clark P; Whitmer J; Frank P; Tantillo C; Arnold E; Hughes SH
J Mol Biol; 1994 Oct; 243(3):472-83. PubMed ID: 7525967
[TBL] [Abstract][Full Text] [Related]
16. The fidelity of misinsertion and mispair extension throughout DNA synthesis exhibited by mutants of the reverse transcriptase of human immunodeficiency virus type 2 resistant to nucleoside analogs.
Taube R; Avidan O; Hizi A
Eur J Biochem; 1997 Nov; 250(1):106-14. PubMed ID: 9431997
[TBL] [Abstract][Full Text] [Related]
17. The carotenoid halocynthiaxanthin: a novel inhibitor of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Loya S; Kashman Y; Hizi A
Arch Biochem Biophys; 1992 Mar; 293(2):208-12. PubMed ID: 1371377
[TBL] [Abstract][Full Text] [Related]
18. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
Loya S; Hizi A
J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
[TBL] [Abstract][Full Text] [Related]
19. A possible role for cysteine residues in the fidelity of DNA synthesis exhibited by the reverse transcriptases of human immunodeficiency viruses type 1 and type 2.
Bakhanashvili M; Hizi A
FEBS Lett; 1992 Jun; 304(2-3):289-93. PubMed ID: 1377646
[TBL] [Abstract][Full Text] [Related]
20. The fidelity of the reverse transcriptases of human immunodeficiency viruses and murine leukemia virus, exhibited by the mispair extension frequencies, is sequence dependent and enzyme related.
Bakhanashvili M; Hizi A
FEBS Lett; 1993 Mar; 319(1-2):201-5. PubMed ID: 7681015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]